Technical Analysis for HROW - Harrow Health, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 10.45 | -3.69% | -0.40 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | -3.69% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | -3.69% | |
| Below Lower BB | Weakness | -3.69% | |
| Down 3 Days in a Row | Weakness | -3.69% | |
| Down 4 Days in a Row | Weakness | -3.69% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 19 hours ago |
| Down 5% | about 20 hours ago |
| Down 3% | about 21 hours ago |
| Expansion Pivot Sell Entry | about 21 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/09/2024
Harrow Health, Inc. Description
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Infectious Diseases Ophthalmology Urology Pharmaceutical Sciences Drug Therapies Compounding
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 28.25 |
| 52 Week Low | 7.6 |
| Average Volume | 483,520 |
| 200-Day Moving Average | 13.24 |
| 50-Day Moving Average | 11.56 |
| 20-Day Moving Average | 12.50 |
| 10-Day Moving Average | 12.30 |
| Average True Range | 0.71 |
| RSI (14) | 34.21 |
| ADX | 23.77 |
| +DI | 19.12 |
| -DI | 30.59 |
| Chandelier Exit (Long, 3 ATRs) | 11.60 |
| Chandelier Exit (Short, 3 ATRs) | 11.42 |
| Upper Bollinger Bands | 14.10 |
| Lower Bollinger Band | 10.89 |
| Percent B (%b) | -0.14 |
| BandWidth | 25.70 |
| MACD Line | 0.01 |
| MACD Signal Line | 0.34 |
| MACD Histogram | -0.3289 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.37 | ||||
| Resistance 3 (R3) | 11.41 | 11.15 | 11.21 | ||
| Resistance 2 (R2) | 11.15 | 10.92 | 11.13 | 11.16 | |
| Resistance 1 (R1) | 10.80 | 10.77 | 10.67 | 10.76 | 11.11 |
| Pivot Point | 10.54 | 10.54 | 10.48 | 10.52 | 10.54 |
| Support 1 (S1) | 10.19 | 10.31 | 10.06 | 10.15 | 9.79 |
| Support 2 (S2) | 9.93 | 10.16 | 9.91 | 9.74 | |
| Support 3 (S3) | 9.58 | 9.93 | 9.69 | ||
| Support 4 (S4) | 9.54 |
